Hideyuki Nakashima

2.0k total citations · 1 hit paper
53 papers, 1.5k citations indexed

About

Hideyuki Nakashima is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Hideyuki Nakashima has authored 53 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Surgery. Recurrent topics in Hideyuki Nakashima's work include Head and Neck Cancer Studies (9 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Hideyuki Nakashima is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Hideyuki Nakashima collaborates with scholars based in Japan, United States and Brazil. Hideyuki Nakashima's co-authors include Kinichi Nakashima, Hirofumi Noguchi, Sumiyo Morita, Takuro Horii, Kenichiro Hata, K. Okamura, Kazuhiko Nakabayashi, Mika Kimura, Izuho Hatada and Atsuhiko Sakai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hideyuki Nakashima

47 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions

2016 378 citations Hirofumi Noguchi, Hideyuki Nakashima et al. profile →

Peers

Countries citing papers authored by Hideyuki Nakashima

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Nakashima more than expected).

Fields of papers citing papers by Hideyuki Nakashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Nakashima. The network helps show where Hideyuki Nakashima may publish in the future.

Co-authorship network of co-authors of Hideyuki Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Nakashima. A scholar is included among the top collaborators of Hideyuki Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Nakashima. Hideyuki Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tripartite Interaction of Epigenetic Regulation, Brain Aging, and Neuroinflammation: Mechanistic Insights and Therapeutic Implications 2025 ·Epigenomes ·Sha Mi, Hideyuki Nakashima, Kinichi Nakashima	0
2	Human microglial cells as a therapeutic target in a neurodevelopmental disease model 2024 ·Stem Cell Reports ·Pinar Mesci, Christopher N. LaRock, (unknown), Hideyuki Nakashima, (unknown), (unknown), Roberto H. Herai, (unknown), (unknown), Cedric E. Snethlage, (unknown), (unknown), Cleber A. Trujillo, Kinichi Nakashima, Victor Nizet, Alysson R. Muotri	7
3	Seizure-induced hilar ectopic granule cells in the adult dentate gyrus 2023 ·Frontiers in Neuroscience ·(unknown), Hideyuki Nakashima, Kinichi Nakashima	7
4	Growth factors with valproic acid restore injury-impaired hearing by promoting neuronal regeneration 2021 ·JCI Insight ·(unknown), Hideyuki Nakashima, (unknown), Teppei Noda, (unknown), (unknown), Yasuhiro Yamada, Takashi Nakagawa, Kinichi Nakashima	12
5	Nox4 Promotes Neural Stem/Precursor Cell Proliferation and Neurogenesis in the Hippocampus and Restores Memory Function Following Trimethyltin-Induced Injury 2018 ·Neuroscience ·(unknown), Tetsuro Ago, Junya Kuroda, Yoshinobu Wakisaka, Masaki Tachibana, (unknown), (unknown), Hideyuki Nakashima, Kinichi Nakashima, Takanari Kitazono	23
6	Therapeutic time window of anti-high mobility group box-1 antibody administration in mouse model of spinal cord injury 2018 ·Neuroscience Research ·(unknown), (unknown), Hideyuki Nakashima, Hidenori Wake, Setsuro Komiya, Masahiro Nishibori, Kinichi Nakashima	15
7	Canonical TGF-β Signaling Negatively Regulates Neuronal Morphogenesis through TGIF/Smad Complex-Mediated CRMP2 Suppression 2018 ·Journal of Neuroscience ·Hideyuki Nakashima, Keita Tsujimura, (unknown), (unknown), Miao Pan, (unknown), Kinichi Nakashima	38
8	Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for T2-4N0 tongue cancer: control of occult neck metastasis 2017 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·(unknown), Kenji Mitsudo, Yuichiro Hayashi, (unknown), Toshinori Iwai, Hideyuki Nakashima, Senri Oguri, (unknown), Toshiyuki Koizumi, Makoto Hirota, Mitomu Kioi, Iwai Tohnai	13
9	Hypoxia Epigenetically Confers Astrocytic Differentiation Potential on Human Pluripotent Cell-Derived Neural Precursor Cells 2017 ·Stem Cell Reports ·(unknown), (unknown), Hideyuki Nakashima, Hirofumi Noguchi, Taito Matsuda, (unknown), Hideyuki Okano, Kinichi Nakashima	22
10	A therapeutic trial of human melanomas with combined small interfering RNAs targeting adaptor molecules p130Cas and paxillin activated under expression of ganglioside GD3 2016 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·(unknown), Kazunori Hamamura, Yoshifumi Takei, Robiul Hasan Bhuiyan, Yuki Ohkawa, Yuhsuke Ohmi, Hideyuki Nakashima, Keiko Furukawa, Koichi Furukawa, (unknown), (unknown)	15
11	M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation 2016 ·Scientific Reports ·(unknown), Mitomu Kioi, Hideyuki Nakashima, Kei Sugiura, Kenji Mitsudo, Ichio Aoki, Hideki Taniguchi, Iwai Tohnai	81
12	MicroRNA-214 Promotes Dendritic Development by Targeting the Schizophrenia-associated Gene Quaking (Qki) 2016 ·Journal of Biological Chemistry ·(unknown), Keita Tsujimura, Hideyuki Nakashima, Kinichi Nakashima	33
13	Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: Analysis of therapeutic results in 112 cases 2014 ·Radiotherapy and Oncology ·Kenji Mitsudo, Toshiyuki Koizumi, (unknown), Toshinori Iwai, Hideyuki Nakashima, Senri Oguri, Mitomu Kioi, Makoto Hirota, Izumi Koike, Masaharu Hata, Iwai Tohnai	46
14	Screening of upper gastrointestinal synchronous double cancer in patients with oral cancer 2014 ·Journal of Japanese Society of Oral Oncology ·Toshinori Iwai, (unknown), Hiroaki Kitajima, (unknown), Hideyuki Nakashima, Senri Oguri, Makoto Hirota, Kenji Mitsudo, Iwai Tohnai	1
15	Functional Activation of Src Family Kinase Yes Protein Is Essential for the Enhanced Malignant Properties of Human Melanoma Cells Expressing Ganglioside GD3 2011 ·Journal of Biological Chemistry ·Kazunori Hamamura, (unknown), Hiroshi Hotta, Yuki Ohkawa, (unknown), (unknown), Hideyuki Nakashima, Yoshio Yamauchi, Noboru Hashimoto, Hisashi Hattori, Minoru Ueda, Keiko Furukawa, Koichi Furukawa, (unknown), (unknown)	62
16	Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors 2011 ·Cancer Immunology Immunotherapy ·Hideyuki Nakashima, Kotaro Miyake, Christopher Clark, Joseph Bekisz, Joel A. Finbloom, Syed R. Husain, Samuel Baron, Raj K. Puri, Kathryn C. Zoon	19
17	Targeting IL‐13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL‐13‐PE and gemcitabine 2010 ·International Journal of Cancer ·Toshio Fujisawa, Hideyuki Nakashima, Atsushi Nakajima, Bharat Joshi, Raj K. Puri	23
18	IL‐13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma 2008 ·International Journal of Cancer ·Mitomu Kioi, Takeshi Shimamura, Hideyuki Nakashima, Makoto Hirota, Iwai Tohnai, Syed R. Husain, Raj K. Puri	20
19	Centrosome Hyperamplification and Chromosomal Damage after Exposure to Radiation 2004 ·Oncology ·Kenji Kawamura, (unknown), Mamoru Ozaki, Kuniyoshi Iwabuchi, Hideyuki Nakashima, (unknown), (unknown), Masao Inoue, Kenzo Tokunaga, (unknown), Ryosuke Ikeda, Koji Suzuki	21
20	The Significance of Peritoneal Cytology in Uterine Cervix and Endometrial Cancer 1997 ·Gynecologic Oncology ·Masamichi Kashimura, (unknown), (unknown), Yusuke Matsuura, Toshinori Kawagoe, Toshiharu Kamura, Tsunehisa Kaku, Nobuhiro Tsuruchi, Hideyuki Nakashima, Hidetaka Sakai	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact